New Federal Conservative government would be wise to increase affordability, accessibility and fairness in the regulatory system: Parliamentary review needed for pharma patents
The new Conservative government has an interesting challenge on many fronts, and from my perspective, sorting out what we will do about pharmaceutical patents should be one of their priorities.
SPONSORED CONTENT
Get Today’s Headlines Newsletter
Your quick scan of the news you need each weekday to be the smartest person in the room.
By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy











